MarketScreener Strategies Genmab A/S Nasdaq
Stocks
GMAB
US3723032062
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 27.91 USD | -2.82% |
|
-3.09% | -9.38% |
| 12:55am | Nordic stocks in North America, Astra Zeneca fell 1.4% | FW |
| 12:39am | Goldman Sachs raises Genmab price target to 2,350 Danish kroner (2,300), reiterates buy - BN | FW |
MarketScreener Strategies
Search
 | Genmab: Financing weighs now, pipeline pays later | June 23, 2026 at 07:20 am EDT |
| Genmab: Market mispricing creates opportunity as good Q1 reinforces investment thesis | May 09, 2026 at 08:05 am EDT |
| Genmab: 2025 miss and cautious 2026 targets erode investor confidence | February 18, 2026 at 09:09 am EST |
| Genmab advances on earnings strength and pipeline while lower valuation opens upside | November 07, 2025 at 10:01 am EST |
| Genmab: A bold shift from defensive to aggressive | September 29, 2025 at 10:45 am EDT |
 | Genmab: From now on, courage to the most patient | April 01, 2025 at 10:57 am EDT |
No results match your criteria
Filters
- Stock Market
- Stocks
- GMAB Stock
- GMAB Stock
- News Genmab A/S
- MarketScreener Strategies
Select your edition
All financial news and data tailored to specific country editions
